Neuropathy Among the Diabetes Control and Complications Trial Cohort 8 Years After Trial Completion

Abstract

The benefits of 6.5 years of intensive therapy on neuropathy status extended for at least 8 years beyond the end of the DCCT, similar to the findings described for diabetic retinopathy and nephropathy.